scispace - formally typeset
Open AccessJournal ArticleDOI

Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis.

Reads0
Chats0
TLDR
In this paper, drug-eluting stents (DES) improve the efficacy of percutaneous coronary intervention by modulating vascular inflammation and preventing neointimal proliferation and restenosis.
Abstract
The cellular and molecular processes that control vascular injury responses after percutaneous coronary intervention involve a complex interplay among vascular cells and progenitor cells that control arterial remodeling, neointimal proliferation, and re-endothelialization. Drug-eluting stents (DES) improve the efficacy of percutaneous coronary intervention by modulating vascular inflammation and preventing neointimal proliferation and restenosis. Although positive effects of DES reduce inflammation and restenosis, negative effects delay re-endothelialization and impair endothelial function. Delayed re-endothelialization and impaired endothelial function are linked to stent thrombosis and adverse clinical outcomes after DES use. Compared with bare-metal stents, DES also differentially modulate mobilization, homing, and differentiation of vascular progenitor cells involved in re-endothelialization and neointimal proliferation. The effects of DES on vascular inflammation and repair directly impact clinical outcomes with these devices and dictate requirements for extended-duration dual antiplatelet therapy.

read more

Citations
More filters
Journal ArticleDOI

Endothelial Microparticle–Mediated Transfer of MicroRNA-126 Promotes Vascular Endothelial Cell Repair via SPRED1 and Is Abrogated in Glucose-Damaged Endothelial Microparticles

TL;DR: In this article, a Taqman microRNA array was performed, and microRNA (miR)-126 was identified as the predominantly expressed miR in EMPs and functionally regulated the target protein sprouty-related, EVH1 domain-conta...
Journal ArticleDOI

Biological responses in stented arteries

TL;DR: It is noteworthy that animals show a rapid progression of healing after stent deployment compared with man, and drugs like rapamycin and paclitaxel have been coated on stent with polymers to allow local slow release of drugs, which have resulted in dramatic reduction of restenosis that was once the Achilles' heel of interventional cardiologists.
Journal ArticleDOI

Exosomes derived from endothelial progenitor cells attenuate vascular repair and accelerate reendothelialization by enhancing endothelial function

TL;DR: The results indicate that exosomes are an active component of the paracrine secretion of human EPCs and can promote vascular repair in rat models of balloon injury by up-regulating endothelial cells function.
Journal ArticleDOI

Oxidative stress and pathological changes after coronary artery interventions.

TL;DR: The molecular mechanisms of ROS generation after coronary interventions, the related pathological events-including restenosis, endothelial dysfunction, and stent thrombosis-and possible therapeutic ways forward are discussed.
Journal ArticleDOI

Surface modification of cardiovascular materials and implants

TL;DR: The blood–biomaterial interfacial events and the evolution of the surface modification strategies are discussed, together with the recent developments on the surface modifications of cardiovascular materials like biomimetic extracellular matrix and accelerated endothelialization, which open a new chapter on designing ideal blood-friendly implantable materials.
References
More filters
Journal ArticleDOI

Isolation of putative progenitor endothelial cells for angiogenesis.

TL;DR: It is suggested that EC progenitors may be useful for augmenting collateral vessel growth to ischemic tissues (therapeutic angiogenesis) and for delivering anti- or pro-angiogenic agents, respectively, to sites of pathologic or utilitarianAngiogenesis.
Journal ArticleDOI

Angiogenesis in cancer, vascular, rheumatoid and other disease

TL;DR: Think of the switch to the angiogenic phenotype as a net balance of positive and negative regulators of blood vessel growth, which may dictate whether a primary tumour grows rapidly or slowly and whether metastases grow at all.
Journal ArticleDOI

Clinical End Points in Coronary Stent Trials A Case for Standardized Definitions

TL;DR: Criteria for assessment of death, myocardial infarction, repeat revascularization, and stent thrombosis were developed and provide consistency across studies that can facilitate the evaluation of safety and effectiveness of these devices.
Journal ArticleDOI

Pathology of Drug-Eluting Stents in Humans: Delayed Healing and Late Thrombotic Risk

TL;DR: The Cypher and Taxus DES result in delayed arterial healing when compared with BMS of similar implant duration, and the cause of DES LST is multifactorial with delayed healing in combination with other clinical and procedural risk factors playing a role.
Related Papers (5)